Answers are grounded in this paper and cite their sources.
Case report reveals acute neuropathy risks in diabetic patients using fluoroquinolone antibiotics, suggesting caution.
Background: Acute Peripheral neuropathy is a significant complication of both Diabetes Mellitus and fluoroquinolone antibiotics. Only a few articles in the literature summarise the findings of acute peripheral neuropathy in the context of diabetic patients taking fluoroquinolone antibiotics. Case Presentation: A 38-year-old female with diabetes was administered Inj. Ciprofloxacin 0.5 mg IV as a test dose to manage the right foot diabetic ulcer, and she developed a sudden burning sensation all over her body. This case report tried to explain the various scientific perspectives on the pathogenesis of acute peripheral neuropathy in a diabetic patient taking fluoroquinolone. The case report discussed is based on findings from the Indian Pharmacopoeia Commission (IPC)-sponsored Pharmacovigilance Programme of India (PvPI) Adverse Drug Reaction (ADR) reporting form. Conclusion: There are multifactorial causes that may synergistically aggravate the acute peripheral neuropathy condition in diabetic patients taking fluoroquinolone antibiotics. There is a need to be very careful while giving fluoroquinolone to a diabetic patient.
No takes yet. Share an insight, caveat, or question.
Alrashid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: